BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

The design of a two-color microarray experiment can be considered as having three layers. Figure 1 shows an example of an experiment that compares the effects of two treatments—A and B—on ...

For the cell biologist, identifying changes in gene expression using DNA microarrays is just the start of a long journey from tissue to cell. We discuss how chip users can first filter noise ...

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...

This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

Growing Adoption of Growth Hormone Therapy, Expanding Estrogen Replacement Programs, and Government-Backed Rare Disease Initiatives Accelerate Turner Syndrome Market Growth.Austin, United States, Feb.

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ ...

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ 49.2 billion by ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare ...

The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and ...

Charles River Laboratories International (NYSE:CRL) reported fourth-quarter and full-year 2025 results that landed at the high end of management’s November outlook, while outlining 2026 guidance that ...

The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and projected to reach US$3.7 billion ...